pokerkit| Shanhe Yaofu: The company's research and development and application of synthetic biotechnology-related technologies are in its infancy

News summary

[Shanhe Pharmaceutical Aid: The company's research and development and application of synthetic biography-related technologies are in its infancy] Securities Times e Company Newspokerkit, some investors asked Shanhe Pharmaceutical Co., Ltd. on the interactive platform: Is the company involved in the synthetic biology business? Shanhe Pharmaceutical Co., Ltd. replied on May 19 that synthetic biotechnology is important in the field of pharmaceutical manufacturingpokerkit...

Newsletter text

[Shanhe Pharmaceutical Aid: The company's research and development and application of synthetic biology-related technologies are in its infancy] Securities Times e Company News, some investors asked Shanhe Pharmaceutical Aid on an interactive platform: Is the company involved in synthetic biology business? Shanhe Pharmaceutical Co., Ltd. replied on May 19 that synthetic biotechnology is an emerging technology in the field of pharmaceutical manufacturing. As a company specializing in the research and development and production of new pharmaceutical excipients, the company has been paying attention to the use of synthetic biotechnology for microcrystalline cellulose and other products in recent years. Production exploration has not yet been industrialized. At present, relevant synthetic biotechnology is applied to the production of some cyclodextrin products of the holding company. The revenue realized by such products accounts for a small proportion of operating income. However, with the continuous development and application of new cyclodextrin products of the company and the broad application of this series of products, there is expected to be good room for growth in the future. Since the company's research and development and application of synthetic biology-related technologies are in its infancy, there is great uncertainty, and some of the products involved account for a small proportion of business. It is expected that it will not have a significant impact on the company's operations for a long time.